ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,485
Screening encounters
2,738
Diagnostic referrals
528
Outstanding pathways
217

Screening pathway

  1. Screening2,738Encounters
  2. Positive finding918Documented findings
  3. Referral528Diagnostic referrals
  4. Follow-up610Diagnostic visits
  5. Outcome311Resolved pathways

Stage totals use different units. Pending pathways: 217. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-03-17, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2485 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3662 · Expanded synthetic participant 3662Site A — Urban Referral Hub
EXP-3663 · Expanded synthetic participant 3663Site C — Rural Outreach Programme
EXP-3666 · Expanded synthetic participant 3666Site A — Urban Referral Hub
EXP-3667 · Expanded synthetic participant 3667Site E — Resource-Constrained Navigation Programme
EXP-3669 · Expanded synthetic participant 3669Site C — Rural Outreach Programme
EXP-3671 · Expanded synthetic participant 3671Site B — Peri-Urban Access Programme
EXP-3672 · Expanded synthetic participant 3672Site A — Urban Referral Hub
EXP-3674 · Expanded synthetic participant 3674Site B — Peri-Urban Access Programme
EXP-3676 · Expanded synthetic participant 3676Site E — Resource-Constrained Navigation Programme
EXP-3677 · Expanded synthetic participant 3677Site A — Urban Referral Hub
EXP-3678 · Expanded synthetic participant 3678Site B — Peri-Urban Access Programme
EXP-3679 · Expanded synthetic participant 3679Site B — Peri-Urban Access Programme
EXP-3682 · Expanded synthetic participant 3682Site D — Community Engagement Programme
EXP-3685 · Expanded synthetic participant 3685Site C — Rural Outreach Programme
EXP-3687 · Expanded synthetic participant 3687Site C — Rural Outreach Programme
EXP-3689 · Expanded synthetic participant 3689Site B — Peri-Urban Access Programme
EXP-3692 · Expanded synthetic participant 3692Site C — Rural Outreach Programme
EXP-3693 · Expanded synthetic participant 3693Site A — Urban Referral Hub
EXP-3694 · Expanded synthetic participant 3694Site D — Community Engagement Programme
EXP-3695 · Expanded synthetic participant 3695Site A — Urban Referral Hub
EXP-3697 · Expanded synthetic participant 3697Site A — Urban Referral Hub
EXP-3699 · Expanded synthetic participant 3699Site A — Urban Referral Hub
EXP-3702 · Expanded synthetic participant 3702Site A — Urban Referral Hub
EXP-3704 · Expanded synthetic participant 3704Site D — Community Engagement Programme
EXP-3705 · Expanded synthetic participant 3705Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1137
HPV DNA
1194
Cytology
407

Navigation activity

Barrier documented
449
Contact attempt
771
Navigation intervention
187
Diagnostic booking
647
Diagnostic visit
610

Documented barriers

Contact difficulty
142
Transport difficulty
143
Appointment coordination
164

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.